CpG-island methylation study of liver fluke-related cholangiocarcinoma
- PMID: 21448164
- PMCID: PMC3078588
- DOI: 10.1038/bjc.2011.102
CpG-island methylation study of liver fluke-related cholangiocarcinoma
Abstract
Background: Genetic changes have been widely reported in association with cholangiocarcinoma (CCA), while epigenetic changes are poorly characterised. We aimed to further evaluate CpG-island hypermethylation in CCA at candidate loci, which may have potential as diagnostic or prognostic biomarkers.
Methods: We analysed methylation of 26 CpG-islands in 102 liver fluke related-CCA and 29 adjacent normal samples using methylation-specific PCR (MSP). Methylation of interest loci was confirmed using pyrosequencing and/or combined bisulfite restriction analysis, and protein expression by immunohistochemistry.
Results: A number of CpG-islands (OPCML, SFRP1, HIC1, PTEN and DcR1) showed frequency of hypermethylation in >28% of CCA, but not adjacent normal tissues. The results showed that 91% of CCA were methylated in at least one CpG-island. The OPCML was the most frequently methylated locus (72.5%) and was more frequently methylated in less differentiated CCA. Patients with methylated DcR1 had significantly longer overall survival (Median; 41.7 vs 21.7 weeks, P=0.027). Low-protein expression was found in >70% of CCA with methylation of OPCML or DcR1.
Conclusion: Aberrant hypermethylation of certain loci is a common event in liver fluke-related CCA and may potentially contribute to cholangiocarcinogenesis. The OPCML and DcR1 might serve as methylation biomarkers in CCA that can be readily examined by MSP.
Figures




Similar articles
-
Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas.Arch Pathol Lab Med. 2007 Jun;131(6):923-30. doi: 10.5858/2007-131-923-MPOMCI. Arch Pathol Lab Med. 2007. PMID: 17550320
-
Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.Mol Cancer. 2011 Aug 26;10:102. doi: 10.1186/1476-4598-10-102. Mol Cancer. 2011. PMID: 21871105 Free PMC article.
-
Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma.Am J Pathol. 2002 Sep;161(3):1015-22. doi: 10.1016/S0002-9440(10)64262-9. Am J Pathol. 2002. PMID: 12213730 Free PMC article.
-
Role of epigenetic alterations in cholangiocarcinoma.J Hepatobiliary Pancreat Surg. 2006;13(4):274-9. doi: 10.1007/s00534-005-1055-3. J Hepatobiliary Pancreat Surg. 2006. PMID: 16858537 Review.
-
Epigenetic alterations in cholangiocarcinoma-sustained IL-6/STAT3 signaling in cholangio- carcinoma due to SOCS3 epigenetic silencing.Digestion. 2009;79 Suppl 1:2-8. doi: 10.1159/000167859. Epub 2009 Jan 20. Digestion. 2009. PMID: 19153483 Review.
Cited by
-
Rhesus monkey model of liver disease reflecting clinical disease progression and hepatic gene expression analysis.Sci Rep. 2015 Oct 7;5:15019. doi: 10.1038/srep15019. Sci Rep. 2015. PMID: 26442469 Free PMC article.
-
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma.Epigenetics. 2012 Nov;7(11):1249-57. doi: 10.4161/epi.22191. Epub 2012 Sep 14. Epigenetics. 2012. PMID: 22983262 Free PMC article.
-
Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases.Clin Epigenetics. 2019 Mar 4;11(1):39. doi: 10.1186/s13148-019-0634-0. Clin Epigenetics. 2019. PMID: 30832707 Free PMC article.
-
The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers.Int J Cancer. 2015 Feb 15;136(4):844-53. doi: 10.1002/ijc.29039. Epub 2014 Jun 28. Int J Cancer. 2015. PMID: 24948044 Free PMC article.
-
Epigenetic Biomarkers and the Wnt/β-Catenin Pathway in Opisthorchis viverrini-associated Cholangiocarcinoma: A Scoping Review on Therapeutic Opportunities.PLoS Negl Trop Dis. 2024 Sep 5;18(9):e0012477. doi: 10.1371/journal.pntd.0012477. eCollection 2024 Sep. PLoS Negl Trop Dis. 2024. PMID: 39236081 Free PMC article.
References
-
- Besson A, Robbins SM, Yong VW (1999) PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis. Eur J Biochem 263: 605–611 - PubMed
-
- Chen WY, Wang DH, Yen RC, Luo J, Gu W, Baylin SB (2005) Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 123: 437–448 - PubMed
-
- Chinnasri P, Pairojkul C, Jearanaikoon P, Sripa B, Bhudhisawasdi V, Tantimavanich S, Limpaiboon T (2009) Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma. Hum Pathol 40: 817–826 - PubMed
-
- Cui Y, Ying Y, van Hasselt A, Ng KM, Yu J, Zhang Q, Jin J, Liu D, Rhim JS, Rha SY, Loyo M, Chan AT, Srivastava G, Tsao GS, Sellar GC, Sung JJ, Sidransky D, Tao Q (2008) OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLoS One 3: e2990. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials